Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)

Université Laval

$97,928.00

Pathogenesis of myotonic dystrophy

FY 2008-09

Summary
Myotonic dystrophy type 1 is the most frequent muscular dystrophy in adult,which affects 1/10,000. No curative treatments are presently available for this disease. The major objective of this proposal is to elucidate the mechanisms that cause Myotonic dystrophy. The results of this research is of major importance for the development of a specific treatment for this muscular dystrophy.
Program
Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
186522
Name
Puymirat Jack
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Muscular Dystrophy Canada (Toronto, Ontario)
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Cell Biology & Mechanisms of Disease
Projecttitle
Pathogenesis of myotonic dystrophy
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$97,928
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)
Keyworddelim
Muscular Dystrophy; Pathogenesis; Rna Splicing; Transgenic Mouse
Abstract
Myotonic dystrophy type 1 is the most frequent muscular dystrophy in adult,which affects 1/10,000. No curative treatments are presently available for this disease. The major objective of this proposal is to elucidate the mechanisms that cause Myotonic dystrophy. The results of this research is of major importance for the development of a specific treatment for this muscular dystrophy.
Competitiondate
200903
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Puymirat, Jack
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $97,928~ $0~
Université Laval - $97,928 Grant (2008-09) | Canada Spends